ctrl K

Watchlist Price Alert

Deep Medicine Acquisition... (DMAQ)

NASDAQ: DMAQ · Real-Time Price · USD

2.96

-5.43 (-64.72%)

At close: Jan 31, 2024, 9:00 PM

Deep Medicine Acquisition Income Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2022	FY 2021
Period Ending	Mar 31, 2023	Mar 31, 2022
Revenue	n/a	n/a
Cost of Revenue	60K	60K
Gross Profit	-60K	-60K
Operating Income	-342.66K	-461.65K
Interest Income	n/a	n/a
Pretax Income	-342.66K	-414.05K
Net Income	-400.23K	-358.18K
Selling & General & Admin	1.91M	409.91K
Research & Development	n/a	n/a
Other Expenses	200K	60K
Operating Expenses	2.11M	409.91K
Interest Expense	n/a	8.27K
Selling & Marketing Expenses	n/a	n/a
Cost & Expenses	2.17M	409.91K
Income Tax Expense	57.57K	-55.87K
Shares Outstanding (Basic)	2.31M	8.74M
Shares Outstanding (Diluted)	2.31M	8.74M
EPS (Basic)	-0.17	-0.04
EPS (Diluted)	-0.17	-0.04
EBITDA	-3.99M	-405.78K
EBIT	n/a	-405.78K
Depreciation & Amortization	-3.65M	55.87K